Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 20 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
191 26.8 months Pleural mesothelioma 5 Chemotherapy
H. Lee Moffitt Cancer Center and Research Institute United States 7/2008
Treatment Details: Patients: This phase II study involved 20 patients with pleural mesothelioma. The majority (75%) were male. Their median age was 67.5, ranging from 46 to 79 years of age. Treatment: Pa
 
192 26.7 months Metastatic breast cancer 4 Biologic therapy
Chemotherapy
Indiana University Cancer Center United States 12/2007
Treatment Details: Patients: This phase 3 study involved 722 women with metastatic breast cancer. They ranged in age from 27 to 85 years of age. The majority had estrogen receptor positive tumors. Treatm
 
193 26.6 months Metastatic breast cancer 4 Chemotherapy
Northwestern University United States 10/2012
Treatment Details: Patients: This phase 2 study involved metastatic breast cancer patients who were divided into two separate treatment groups. Group A consisted of 76 women with a median age of 51.7 years.
 
194 26.6 months Peripheral T-Cell lymphoma 5 Biologic therapy
Chemotherapy
Hormone
Samsung Medical Center Korea 7/2012
Treatment Details: Patients: This study involved 46 peripheral T-Cell lymphoma patients with a median age of 51 years. Of these, 54.3% were male. Treatment: Patients were treated with the biologic therap
 
195 26.5 months Newly diagnosed GBM 3 Biologic therapy
Chemotherapy
Radiation
Surgery
University of Regensburg Germany 4/2004
Treatment Details: Patients: This Phase II study involved a total of 23 patients: 10 with glioblastoma multiforme, 7 with anaplastic astrocytoma, 5 with anaplastic oligoastrocytoma, and 1 with anaplastic oligo
 
196 26.4 months Stage III NSCLC 4 Chemotherapy
Radiation
Shinshu University School of Medicine Japan 5/2009
Treatment Details: Patients: This study involved 34 patients with stage III non-small cell lung cancer. The majority (32) were men. The median age was 61.4 years, ranging from 45 to 75. Treatment: Patient
 
197 26.3 months Invasive Bladder Cancer 3 Radiation
Karadeniz Technical University Turkey 11/2014
Treatment Details: Patients: This study involved 314 invasive bladder cancer patients. The average patient age was 69.18 years and 90.7% were male. Treatment: Patients received concomitant boost and acce
 
198 26.0 months NHL 5 University of Minnesota and VAMC United States 8/2014
Treatment Details: Patients: This phase 2 study involved 53 relapsed/refractory mantle cell lymphoma patients. The median patient age was 67 years and 83% were male. Treatment: Patients received biologic
 
199 26.0 months Metastatic and recurrent breast cancer 4 Chemotherapy
Kurume University Japan 7/2013
Treatment Details: Patients: This phase 2 study involved 40 female metastatic and recurrent breast cancer patients with an average age of 59.4 years. Treatment: Patients received chemotherapy with irinote
 
200 26.0 months Mesothelioma 3 Chemotherapy
Immunotherapy
Radiation
Surgery
University of Pisa Italy 12/2006
Treatment Details: Patients: This phase II study involved 49 patients with stage II-III malignant pleural mesothelioma. There were 41 men and 8 women, with a median age of 61 years (ranging from 41-77). T
 
Page 20 of 187  | Previous Page  | Next Page